Cargando…
Dose response of ACE inhibitors: implications of the SECURE trial
The choice of the appropriate dosage of ACE inhibitor in clinical practice is an important one. The available evidence suggests that in chronic heart failure as well as in chronic coronary artery disease, high doses of angiotensin-converting enzyme (ACE) inhibitor are more effective than low ones. T...
Autor principal: | Lonn, Eva |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC59639/ https://www.ncbi.nlm.nih.gov/pubmed/11806789 http://dx.doi.org/10.1186/cvm-2-4-155 |
Ejemplares similares
-
ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010) -
Simulation-based training of surgical skills
por: Konge, L., et al.
Publicado: (2016) -
COVID-19 and Global Health Security: Overview of the Global Health Security Alliance, COVID-19 Response, African Countries’ Approaches, and Ethics
por: Yimer, Belete, et al.
Publicado: (2020) -
ACE polymorphisms and COVID-19-related mortality in Europe
por: Bellone, Matteo, et al.
Publicado: (2020) -
COVID-19, diabetes mellitus and ACE2: The conundrum
por: Pal, Rimesh, et al.
Publicado: (2020)